Regulatory excellence in pharmaceutical logistics compliance
Every pharma compliance certificate on our wall exists because a shipment demanded it. We do not collect credentials for display — we earn them through documented processes, validated equipment, and the rigorous standards your products require.
The pharma compliance framework that governs every shipment
Pharmaceutical logistics compliance operates within a dense regulatory environment. EU Directive 2001/83/EC, WHO Technical Report Series No. 961, and national implementations such as Germany's Arzneimittelgesetz (AMG) all define how medicinal products must be stored, handled, and transported.
The WHO estimates that up to 50% of vaccines are wasted globally each year — largely due to weak temperature control and broken logistics chains. Annual losses from temperature excursions across the pharmaceutical industry reach $15 billion.
Understanding these regulations is not optional. It is the baseline for pharma compliance in every pharmaceutical shipment we handle.
Key Regulations
Distribution of medicinal products across the EU
Qualification and validation of equipment and processes
Air transport of dangerous goods and temperature-controlled cargo
German wholesale distribution licence requirements
Model guidance for storage and transport of pharmaceuticals
What each standard means — and why it matters
Compliance is not a checkbox exercise. Each standard addresses a specific risk in the pharmaceutical supply chain.
Good Distribution Practice
GDP defines the minimum standard for the distribution of medicinal products within the EU. It covers everything from warehouse qualification to transport validation, staff training to deviation management. Without GDP adherence, pharma compliance cannot be demonstrated — temperature-controlled shipments lack the documented chain of evidence that regulators and quality teams require.
Covers the entire distribution chain — from manufacturer release to pharmacy receipt.
IATA Dangerous Goods & Pharma Handling
Air transport of pharmaceutical products requires compliance with IATA's Dangerous Goods Regulations and the CEIV Pharma certification standard. This governs labelling, packaging, time-and-temperature management, and the handling protocols airlines must follow for sensitive cargo.
Mandatory for any pharmaceutical air freight — no exceptions.
Good Manufacturing Practice
While GMP primarily governs manufacturing, its principles extend into logistics wherever product integrity is at stake. Transport conditions must not compromise what was achieved in a GMP-certified production environment. This means validated packaging, controlled environments, and complete traceability.
The logistics chain must preserve what the cleanroom achieved.
LBA Known Consignor / Regulated Agent
Approval by Germany's Luftfahrt-Bundesamt (LBA) as a Known Consignor or Regulated Agent certifies that our facilities and processes meet aviation security standards. This allows direct handover of cargo to airlines without additional screening — reducing handling time and risk exposure for time-critical shipments.
Faster, more secure access to air freight capacity.
Verified credentials, not marketing claims
Each certification is subject to regular audits and recertification. We maintain active compliance — not historical credentials.
Matching temperature control to product requirements
Different pharmaceutical products demand different thermal environments. The right combination of packaging, monitoring, and process determines compliance.
| Temperature Range | Typical Products | Packaging | Monitoring |
|---|---|---|---|
+15°C to +25°C CRT | Tablets, capsules, medical devices | Insulated shippers with PCM packs | Data logger, min/max recording |
+2°C to +8°C Cold | Vaccines, insulin, biologics, sera | Qualified cold boxes, gel packs | Continuous digital temperature logger |
-25°C to -15°C Frozen | Plasma products, enzyme preparations | Insulated containers, dry ice supplement | Dual-sensor logger with alarm threshold |
-70°C to -80°C Ultra-cold | mRNA vaccines, certain cell therapies | Dry ice shippers, validated hold time | Pre-calibrated logger, GPS tracking |
Below -150°C Cryogenic | Cell & gene therapies, tissue samples | Liquid nitrogen dewars (LN²) | Continuous cryo-logger, chain of custody |
Temperature ranges follow ICH stability guidelines and WHO Technical Report Series recommendations. Actual packaging qualification depends on lane-specific conditions, season, and transit duration.
Five steps from shipment request to audit-ready documentation
We evaluate your product's stability profile, regulatory classification, and transport requirements. This determines the applicable standards and documentation scope.
Selected packaging undergoes performance qualification (PQ) testing against the specific route profile — accounting for climate zones, transit duration, and seasonal variation.
Real-time temperature monitoring begins at collection. GPS tracking, digital data loggers, and defined escalation protocols ensure continuous oversight throughout transit.
If a temperature excursion occurs, we apply Mean Kinetic Temperature (MKT) analysis alongside your product's stability data. The CAPA process documents root cause, corrective action, and preventive measures.
Complete transport records — including temperature logs, chain of custody, customs documentation, and deviation reports — are compiled into an audit-ready packet delivered alongside your shipment.
Document Checklist
- Temperature monitoring certificate
- Chain of custody record
- Packaging qualification report
- Route risk assessment
- Customs clearance documentation
- Deviation / CAPA report (if applicable)
- Certificate of compliance
ALCOA+ Data Integrity
All documentation follows the ALCOA+ framework:
Plus: complete, consistent, enduring, and available.
Ensure pharma compliance for your next pharmaceutical shipment
Whether you are shipping clinical trial material, commercial biologics, or research samples — pharma compliance is not negotiable. Let us handle the complexity.
Nehmen Sie Kontakt auf